scholarly journals Pamidronate and zoledronate effects in the increment of bone mineral density and histomorphometry in rats

2011 ◽  
Vol 26 (2) ◽  
pp. 114-120
Author(s):  
Antônio Fiel Cruz Júnior ◽  
Carlos Buchpiguel ◽  
Roberto Guarniero ◽  
Antonio Barbieri
Keyword(s):  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Mineral ◽  
Young Female ◽  
Female Rats ◽  
Laboratory Evaluation ◽  
Control Group ◽  
Biochemical Evolution ◽  
Mineral Density ◽  
Total Proteins

PURPOSE: To compare increment of bone mineral density (BMD) with pamidronate, zoledronate and the isolated effect of proteinous diet in undernourished oophorectomized and non-oophorectomized female rats, besides validating BMD's indexes. METHODS: 60 young female Lewis rats were divided into five experimental groups and a control group, oophorectomized and non-oophorectomized. The administration of drugs were submitted to proteinous and aproteinous diets. The variables analyzed were weight, bone densitometry, histomorphometry and biochemical evolution. RESULTS: In weight evaluation, the first interval showed a statistically meaningful increase in oophorectomized sample. In densitometry evaluation, the first interval showed statistically meaningful decrease in four medicated groups and third showed a statistically meaningful increase in 2 non-oophorectomized groups. In laboratory evaluation, there were an increase of total proteins and globulin, decrease of alkaline phosphatase, phosphorus and calcium (except for the oophorectomized) in four medicated groups and increase of phosphorus and calcium in 2 not medicated groups. In histomorphometric evaluation, the oophorectomized groups had smaller increment of BMD. CONCLUSIONS: The pamidronate and zoledronate have shown effectives in the increment of BMD. The proteinous diet itself possesses therapeutic effect in BMD though not significant compared with medicated animals. The results of histomorphometry allow validating BMD's indexes in this experimental model.

scholarly journals Bone mineral density and bone metabolic markers in laboratory in men with marfanoid habitus

2017 ◽  
Vol 8 (6) ◽  
pp. 42-49
Author(s):  
Evgeny V. Timofeev ◽  
Tatiana I. Belousova ◽  
Elena V. Vutrih ◽  
Eduard V. Zemtsovsky ◽  
Andrey Yu. Olkhovik
Keyword(s):  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Tissue ◽  
Bone Mineral ◽  
Diagnostic Algorithm ◽  
Control Group ◽  
Mineral Density ◽  
Metabolic Markers ◽  
Power Shortages ◽  
Increased Activity

The aim of the research was the study of bone mineral density (BMD) and activity laboratory markers of bone metabolism in juniors with power shortages and marfanoid habitus (MH). Materials and methods: Twenty 119 males are underweight aged 18 to 25 years old (average age of 20.4 ± 1.5 years). All surveyed was conducted anthropometric, phenotypical, Echocardiography study to identify the mitral valve prolapse (MVP), laboratory examination of the bone forming token (Osteocalcin, alkaline phosphatase), and the dissolution of bone tissue (β-CrossLaps), Dual-energy X-ray densitometry (L1-L4). Results: Revealed a significant reduction in BMD females with MH as compared to control (Z-criterion –1.23 ± 0.73 and 0.34 ± 0.80, STD, respectively, p < 0.00001). BMD significant decrease (–1.5 STD) found a third of individuals with MH and not seen in the control group, p = 0.01. When assessing young BMD depending on the severity of MVP statistically reliable differences had been received. At the same time that boys with MVP in conjunction with signs MH is characterized by the lowest BMD values. In the analysis of laboratory parameters revealed a significant increase in Osteocalcin and alkaline phosphatase in the Group of persons with MH, indicating bone forming activity in these patients. At the same time, for people with MH is characterized by increasing the level of β-CrossLaps (marker of the dissolution of bone tissue). With the increased activity of the dissolution of bone tissue associated bone such signs as dolyhostenomelia, deformations of thorax and arachnodaktylia. Conclusion: bone signs dysembriogenesis involved in the diagnostic algorithm MH, contributes to the abnormal formation of bone tissue in these patients. For them is characterized by activation synthesis and dissolution of bone tissue, reducing BMD.

scholarly journals The effects of royal jelly protein on bone mineral density and strength in ovariectomized female rats

2021 ◽  
Vol 25 (2) ◽  
pp. 33-37
Author(s):  
Satoshi Hattori ◽  
Naomi Omi
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Royal Jelly ◽  
Female Rats ◽  
Control Group ◽  
Dependent Manner ◽  
Mineral Density ◽  
Royal Jelly Protein

[Purpose] Sex hormones deficiency leads to dramatically bone loss in particular postmenopausal women. Royal jelly has anti-osteoporosis effect due to maintain bone volume in that condition. We hypothesized that royal jelly protein (RJP, a latent residue after extracting royal jelly) also prevents bone deficient in ovariectomized (OVX) female rats, the animal model of postmenopausal women. [Methods] Female Sprague-Dawley rats (n = 30, 6 weeks age old) were sham operated (Sham; sham operated group, n = 7), OVX control group (OC, n = 7), OVX with low RJP intake group (ORL, n = 8), and OVX with high RJP intake group (ORH, n = 8) during 8 weeks experimental periods. In the end point of this experiment, the bone samples (lumbar spine, tibia, and femur) were surgically removed under anesthesia. These bone samples were evaluated bone mineral density (BMD) and bone strength.[Results] BMD of lumbar spine in RJP intake groups (ORL, ORH) were higher than that in OC group (p < 0.05 and p < 0.01) in RJP intake volume dependent manner. BMD of tibial proximal metaphysis and diaphysis in RJP intake groups were also higher than these in OC group (p < 0.01 and p < 0.01 / p < 0.05 and p < 0.001). In addition, breaking force of femur in RJP intake groups were significantly increase compared with that in OC group (p < 0.001 respectively). [Conclusion] These findings indicate that RJP contribute to prevent sex hormone related bone abnormality

scholarly journals The influence of prolactin on bone mineral density (BMD) and some biochemical markers of ovariectomized rats

2010 ◽  
Vol 55 (No. 2) ◽  
pp. 83-88
Author(s):  
B. Dolińska ◽  
A. Suszka-Świtek ◽  
S. Dragan ◽  
F. Ryszka ◽  
R. Kołacz ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Acid Phosphatase ◽  
Bone Mineral ◽  
Biochemical Markers ◽  
Ovariectomized Rats ◽  
Control Group ◽  
Osseous Tissue ◽  
Mineral Density ◽  
Healthy Group

A model of postmenopausal osteoporosis was used in the study. 107 days after ovariectomy the animals were subcutaneously applied 1.0 IU PRL/kg BM or 1.0 IU calcitonin/kg BM for 7 days in single doses. The application of the preparations started again 80 days after the first application. After 194 days the animals were narcotized, blood was collected, and lumbar (L2–L4) and femoral bones were prepared. The material obtained was subjected to densitometric analysis of bone mineral density (BMD). In ovariectomized rats the loss of osseous tissue was observed only in the lumbar bone. The application of prolactin to ovariectomized rats caused an increase in the mineral density of the lumbar bone up to a BMD value equal to that of the control group which had not been subjected to ovariectomy (control healthy group – SHAM). Similar results were obtained in the case of calcitonin. An increase in osteocalcin concentration and activity of isoenzyme alkaline phosphatase (BAL), with a decrease in the activity of isoenzyme acid phosphatase (TRAP) was observed in experimental groups compared to control ones.

Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study

2021 ◽  
Vol 34 (4) ◽  
pp. 441-447
Author(s):  
Ismail Solmaz ◽  
Mehmet Akif Ozdemir ◽  
Ekrem Unal ◽  
Ummuhan Abdurrezzak ◽  
Sebahattin Muhtaroglu ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Acute Lymphoblastic Leukemia ◽  
Bone Mineral ◽  
Vitamin D3 ◽  
Lymphoblastic Leukemia ◽  
Vitamin K2 ◽  
Control Group ◽  
Study Group ◽  
Mineral Density

Abstract Objectives Current treatment protocols in acute lymphoblastic leukemia (ALL) are associated with high remission rates and long life expectancy, enhancing the importance of quality of life and prevention of treatment-related complications in patient care. As osteoporosis is a frequent complication in patients under chemotherapy, we investigated the effect of vitamin K2 (100 mcg menaquinone-7) and vitamin D3 (10 mcg calcitriol) on bone metabolism in children with ALL. Methods Twenty-nine consecutive patients recently diagnosed with B precursor ALL (B-ALL) and treated according to the Turkish Acute Lymphoblastic Leukemia Berlin Frankfurt Münster 2000 protocol were randomly assigned into study and control groups. The study group (n=15, M/F: 8/7, age 1–14.5 years, mean 6.5 years) received vitamin K2 and vitamin D3 with their chemotherapy, while the control group (n=14, M/F 9/5, age 2–17 years, mean 7.1 years) received chemotherapy only. Serum calcium, phosphorus, magnesium, alkaline phosphatase, bone-specific alkaline phosphatase, uncarboxylated osteocalcin (ucOC), tartrate resistant acid phosphatase 5b, carboxyl terminal procollagen propeptide (PICP), osteoprotegerin (OPG), and receptor activator nuclear kappa B ligand (RANKL) were measured and bone mineral density (BMD) was determined at baseline and first, second, third and sixth months. Results The study group had higher serum OPG/RANKL ratio and lower ucOC levels compared to the control group at the first month; PICP levels were higher in the study group at second and third months. Conclusions These results suggest an early beneficial effect of the combination of vitamin K2 and vitamin D3 on BMD in ALL patients especially during the period of intensive steroid therapy in the first months.

Downhill running increases bone mass accumulation and bone tissue morphology through TGF- β /Smad pathway in mice

2020 ◽  
Author(s):  
Xianghe Chen ◽  
Peng Sun ◽  
Aiguo Chen ◽  
Haixia Peng ◽  
Xianliang Zhang ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Mass ◽  
Bone Tissue ◽  
Bone Mineral ◽  
Osteoblastic Differentiation ◽  
Control Group ◽  
Mineral Density ◽  
Smad Pathway ◽  
Downhill Running

Abstract Background: Compelling evidence has demonstrated that impact exercise can help to accumulate more bone mass. However, the cellular mechanism is less clear. The current study aimed to examine the effects of downhill running on osteoblast formation and the ability of mineralization in mice. The expression of transforming growth factor-b (TGF-b)/Smad pathway molecules was also determined. Methods: Twenty-eight 4-week-old C57BL/6 female mice were randomly assigned to either downhill running group (DG) or control group (CG). DG mice received a daily forty-minute downhill training on a decline treadmill (9 o decline) for 8 weeks. Eight weeks later, all mice were killed. Bone marrow stromal cells were collected and cultured for assessment of osteoblastic differentiation and the capacity of osteoblastic mineralization. We determined the protein (Western Blot) and mRNA (RT-PCR) expression of TGF-b, p-Smad2/3/4, and Runx2 in bone tissue. The bone mineral density (BMD) and histomorphological changes were also examined. Results: Eight-week training significantly increased bone mineral density (BMD) and enhanced the expression of alkaline phosphatase positive (ALP + ) osteoblasts in tibia epiphysis. Downhill running also promoted bone volume fraction (BV/TV), trabecular number (Tb.N) and trabecular thickness (Tb.Th), while it decreased the trabecular separation (Tb.Sp). Additionally, the numbers of alkaline phosphatase positive colony forming units-fibroblastic (ALP ＋ CFU-f) cells and the area of mineralized nodule formation were significantly higher in training group compared with the control group. Furthermore, the mRNA expression of TGF-b, Smad2, Smad3, Smad4 and Runt-related transcription factor 2 (Runx2) were significantly elevated by downhill training, and the protein expression of p-Smad2, p-Smad3, p-Smad4 and Runx2 also increased in exercise group. Conclusion: The findings suggested that downhill running enhanced bone accrual in mice mainly by promoting osteoblastic differentiation and the ability of mineralization. The beneficial changes partly be regulated by TGF-b/Smad signaling pathway.

scholarly journals Preventive effects of a herbal medicine on bone loss in rats treated with a GnRH agonist

2000 ◽  
pp. 139-142 ◽  
Author(s):  
S Sakamoto ◽  
S Sassa ◽  
H Kudo ◽  
S Suzuki ◽  
T Mitamura ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Herbal Medicine ◽  
Bone Loss ◽  
Bone Mineral ◽  
Gnrh Agonist ◽  
Female Rats ◽  
Control Group ◽  
Mineral Density ◽  
Conjugated Estrogens ◽  
Traditional Chinese Herbal Medicine

The study was designed to evaluate the effects of a traditional Chinese herbal medicine Hochu-ekki-to (Bu-zong-yi-qi-tang), which was composed of 10 herbal medicines and had been used for the treatment of oligospermia and as a postoperative medication in Japan, on bone loss in rats treated with a gonadotropin-releasing hormone (GnRH) agonist. Female rats at 40 weeks of age were divided into 4 groups of 8 rats each. In the three experimental groups, each animal received subcutaneous injections of the long-acting GnRH agonist, buserelin acetate, once every four weeks throughout the experiment. Beginning at 48 weeks of age, the experimental groups were given diets containing conjugated estrogens or Hochu-ekki-to for 8 weeks. The administration of the GnRH agonist reduced the bone mineral density in the whole femur to 91.0% of that in the control group. However, administration of conjugated estrogens and Hochu-ekki-to increased the serum concentrations of estradiol 16.8- and 5.3-fold respectively compared with concentrations in the GnRH agonist-treated group, resulting in the augmentation of the bone mineral density to 110.3% and 106.2% respectively. These findings indicate that Hochu-ekki-to enhances the reduced bone mineral density and causes a slight elevation of the serum estradiol levels in the chemically castrated rats.

Impaired Estrogen Sensitivity in Bone by Inhibiting Both Estrogen Receptor a and b Pathways*

2020 ◽  
Author(s):  
Lungwani Muungo
Keyword(s):  
Bone Mineral Density ◽  
Estrogen Receptor ◽  
Bone Loss ◽  
Bone Turnover ◽  
Bone Mineral ◽  
Female Rats ◽  
Wild Type ◽  
Mineral Density ◽  
Transgenic Rats ◽  
Estrogen Sensitivity

Although it is well established that estrogen deficiencycauses osteoporosis among the postmenopausalwomen, the involvement of estrogen receptor (ER) in itspathogenesis still remains uncertain. In the presentstudy, we have generated rats harboring a dominantnegative ERa, which inhibits the actions of not only ERabut also recently identified ERb. Contrary to our expectation,the bone mineral density (BMD) of the resultingtransgenic female rats was maintained at the same levelwith that of the wild-type littermates when sham-operated.In addition, ovariectomy-induced bone loss wasobserved almost equally in both groups. Strikingly, however,the BMD of the transgenic female rats, after ovariectomized,remained decreased even if 17b-estradiol(E2) was administrated, whereas, in contrast, the decreaseof littermate BMD was completely prevented byE2. Moreover, bone histomorphometrical analysis ofovariectomized transgenic rats revealed that the higherrates of bone turnover still remained after treatmentwith E2. These results demonstrate that the preventionfrom the ovariectomy-induced bone loss by estrogen ismediated by ER pathways and that the maintenanceof BMD before ovariectomy might be compensatedby other mechanisms distinct from ERa and ERbpathways.

Effects of One-Year Adjuvant Treatment with Tamoxifen on Bone Mineral Density in Postmenopausal Breast Cancer Women

1996 ◽  
Vol 82 (1) ◽  
pp. 65-67 ◽  
Author(s):  
Sandro Barni ◽  
Paolo Lissoni ◽  
Gabriele Tancini ◽  
Antonio Ardizzoia ◽  
Marina Cazzaniga
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Adjuvant Treatment ◽  
Mineral Content ◽  
Postmenopausal Breast Cancer ◽  
Mineral Density ◽  
One Year

In this study, the authors have analyzed the possible effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women. Bone mineral content was studied by photon absorptiometry (I-125), whereas bone balance was analyzed indirectly by serum PTH, osteocalcin, calcitonin, calcium and alkaline phosphatase levels. Bone mineral content and serum bone-related substances were measured before starting treatment and after one year. Results were analyzed using Student's t test for paired data. No difference was found between the two measurements for bone mineral content, PTH, calcitonin, calcium and alkaline phosphatase levels. Measurements at entry and after one year of treatment showed a statistically significant difference ( P < 0.001) only for osteocalcin. In accordance with other authors, we can conclude that treatment with tamoxifen does not cause an increase in menopausal bone resorption. The finding that osteocalcin levels decreased after one year of therapy with tamoxifen is interesting, but further studies are necessary to clarify the role of such levels in predicting a turnover of bone balance towards osteoblastic activity.

Sign in / Sign up

Export Citation Format

Share Document